April 2017 | Volume 1

Dr. Pracyk is Franchise Medical Director for DePuy Synthes Spine, providing clinical insight to colleagues across R&D, marketing, clinical/regulatory affairs and business development.

Whether you're an OEM or a contract manufacturer, margin preservation is critical to success. There are ways, even in challenging times, to reduce cost and lead times while improving margins, explains David Finch.

Of 51 products gaining clearance under FDA's Orthopedic Panel in March, we highlight the following four: a cannular system, unicompartmental knee, clavicle pin and revision tibial system.

The joint reconstruction segment is a priority for the five leading orthopaedic companies: DePuy Synthes, Zimmer Biomet, Stryker, Smith & Nephew...and yes, even Medtronic.

All design changes must be verified and validated, unless you can document that verification alone is appropriate.

June 13-15 | Chicago

Contact any sponsor to secure a promo code for savings on your 






OMTEC Quick Links: